Amy Harrington, MD

UMass Mind Clinical and Research Program, UMass Memorial Health/University of Massachusetts Chan Medical School, Worcester, Massachusetts

  • 1Article
  • 2025Active
  • 4Collaborators

About

Amy Harrington, MD is affiliated with UMass Mind Clinical and Research Program, UMass Memorial Health/University of Massachusetts Chan Medical School, Worcester, Massachusetts. Amy Harrington has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2025. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Publications

JCP
Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder
Original Research

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe